Peptide conjugates for labelling endogenous gipr and glp-1r
AssigneesForschungsverbund Berlin E.V., The University of Birmingham
InventorsJohannes BROICHHAGEN, David HODSON
Life of this patent
Estimating the term…
Loading patent…
AssigneesForschungsverbund Berlin E.V., The University of Birmingham
InventorsJohannes BROICHHAGEN, David HODSON
Estimating the term…
The invention relates to a peptide conjugate comprising a peptide covalently linked to a label, wherein the peptide comprises an amino acid sequence of a protein ligand that binds at least one class B1 G protein-coupled receptor, wherein the peptide is covalently linked to the label. The protein ligand is preferably an agonist, antagonist and/or co-agonist of at least one class B1 G protein-coupled receptor, preferably from the Glucagon-like subfamily. The agonist, antagonist and/or co-agonist is preferably selected from tirzepatide, LY3437943 or GIP. The invention further relates to kits comprising the peptide conjugate according to the invention or means for assembling the conjugate, as well as methods for using the peptide conjugate according to the invention.
A peptide conjugate comprising a peptide and a label,
(canceled)
(canceled)
-17. (canceled)
-29. (canceled)
Dependencies are inferred from the claim text.